Natalie Engmann, PhD, MSc

Clinical and Health Economic Outcomes Lead
Denali Therapeutics, South San Francisco, CA, USA

Poster(s):

• (371) Clinical and economic burden of patients with Hunter Syndrome in the United States: a retrospective cohort study
  Wednesday, October 29, 2025